Advertisement
Screener

NRC Health (NRC) Return on Tangible Equity

2.8 / 5 stars · 68/120 Roast Me

NRC HEALTH Return Tang Equity

Return on tangible equity is the profit a company earns on the physical and financial capital its shareholders own, leaving out goodwill and other intangible assets, shown as a percentage. It is net income divided by tangible equity, which is shareholder equity minus goodwill and intangibles; the table shows both amounts. Because acquired goodwill is removed, it runs higher than ROE for companies that grew by acquisition, and it has no meaning when goodwill exceeds equity. Goodwill and intangibles are taken at the latest reported date on or before each equity date. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • NRC HEALTH return tang equity for the quarter ending 2026-03-31 was -16.83%, a change of 47.04% year-over-year.
  • NRC HEALTH return tang equity for the quarter ending 2025-12-31 was -21.81%, a change of 46.48% year-over-year.
  • NRC HEALTH return tang equity for the quarter ending 2025-09-30 was -30.72%, a change of 54.26% year-over-year.
  • NRC HEALTH return tang equity for the quarter ending 2025-06-30 was -38.77%, a change of 96.13% year-over-year.
  • NRC HEALTH return tang equity for fiscal 2025 was -21.81%, a change of 46.48% from fiscal 2024.
  • NRC HEALTH return tang equity for fiscal 2024 was -68.29%, a change of 171.08% from fiscal 2023.
  • NRC HEALTH return tang equity for fiscal 2023 was -239.36%, a 175.26% decline from fiscal 2022.
  • NRC HEALTH return tang equity for fiscal 2022 was 318.03%, a 96.29% increase from fiscal 2021.
Available history
2009-12-31 to 2026-03-31
Data captured

Historical Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2026-03-31-16.83%$9.04M-$53.69M
2025-12-31-21.81%$11.6M-$53.2M
2025-09-30-30.72%$16.36M-$53.26M
2025-06-30-38.77%$17.93M-$46.25M
2025-03-31-63.87%$24.21M-$37.91M
2024-12-31-68.28%$24.78M-$36.29M
2024-09-30-84.98%$27.08M-$31.87M
2024-06-30-134.90%$29.27M-$21.7M
2024-03-31-121.71%$30.37M-$24.95M
2023-12-31-239.36%$30.97M-$12.94M
2023-09-30-690.87%$28.75M-$4.16M
2023-06-30185.65%$29.18M$15.72M
2023-03-31239.29%$30.23M$12.63M
2022-12-31318.03%$31.8M$10M
2022-09-30626.54%$34.79M$5.55M
2022-06-30563.89%$36.15M$6.41M
2022-03-31190.80%$36.77M$19.27M
2021-12-31162.02%$37.47M$23.12M
2021-09-30169.27%$36.05M$21.3M
2021-06-30247.94%$35.97M$14.51M
2021-03-31304.26%$34.74M$11.42M
2020-12-31544.66%$37.26M$6.84M
2020-09-30-2242.78%$37.75M-$1.68M
2020-06-30-283.67%$36.29M-$12.79M
2020-03-31-171.38%$35.97M-$20.99M
2019-12-31-126.68%$32.41M-$25.58M
2019-09-30-105.62%$31.51M-$29.83M
2019-06-30-92.44%$30.38M-$32.87M
2019-03-31-85.82%$30.94M-$36.05M
2018-12-31-75.76%$30.05M-$39.66M
2014-09-3070.77%$17.82M$25.18M
2014-06-3082.02%$17.08M$20.83M
2014-03-31101.83%$16.47M$16.17M
2013-12-31147.28%$15.48M$10.51M
2013-09-30294.44%$15.42M$5.24M
2013-06-301527.57%$15.18M$994,000.00
2013-03-31-655.89%$15.69M-$2.39M
2012-12-31-266.22%$15.07M-$5.66M
2012-09-304165.80%$14.5M$348,000.00
2012-06-30-535.40%$13.57M-$2.53M
2012-03-31-226.76%$11.96M-$5.27M
2011-12-31-143.51%$11.56M-$8.06M
2011-09-30-239.06%$10M-$4.18M
2011-06-30-188.21%$9.5M-$5.05M

Annual Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2025-12-31-21.81%$11.6M-$53.2M
2024-12-31-68.29%$24.78M-$36.29M
2023-12-31-239.36%$30.97M-$12.94M
2022-12-31318.03%$31.8M$10M
2021-12-31162.02%$37.47M$23.12M
2020-12-31544.66%$37.26M$6.84M
2019-12-31-126.68%$32.41M-$25.58M
2018-12-31-75.76%$30.05M-$39.66M
2017-12-3175.35%$22.94M$30.45M
2016-12-3189.16%$20.52M$23.01M
2013-12-31147.28%$15.48M$10.51M
2012-12-31-266.22%$15.07M-$5.66M
2011-12-31-143.51%$11.56M-$8.06M
2010-12-31-129.78%$8.5M-$6.55M
2009-12-3119.22%$8.49M$44.17M

Similar stocks

Stock NameCountryMarket CapPE Ratio
OmniAb, Inc. (OABI)United States$0.698B-8.05
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B
FOXO TECHNOLOGIES INC. (FOXO)United States$0.000B-277.71
Absci Corp (ABSI)United States$1.775B-14.92
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)United States$14.060B-43.97
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14